As observed from the rheumatoid arthritis (RA) mouse model, blocking NKG2A accelerated NK cell mediated elimination of pathogenic T helper 17 (Th17) cells as well as follicular helper T (Tfh) cells, thus arresting disease progression (104). Here, KLRC1 is linked to rheumatoid arthritis.